All Stories

  1. 68Ga-PSMA PET/CT imaging of metastatic clear cell renal cell carcinoma

    Article • European Journal of Pediatrics, April 2014, Springer Science + Business Media

    Clemens Decristoforo

  2. Tumor targeting and imaging with dual-peptide conjugated multifunctional liposomal nanoparticles

    Article • International Journal of Nanomedicine, December 2013, Taylor & Francis

    Clemens Decristoforo, Professor Ruth Prassl, Dr Christine Rangger

  3. A retrospective comparison between 68Ga-DOTA-TOC PET/CT and 18F-DOPA PET/CT in patients with extra-adrenal paraganglioma

    Article • European Journal of Pediatrics, September 2013, Springer Science + Business Media

    Clemens Decristoforo

  4. 68Ga-Triacetylfusarinine C and 68Ga-Ferrioxamine E for Aspergillus Infection Imaging: Uptake Specificity in Various Microorganisms

    Article • Molecular Imaging and Biology, July 2013, Springer Science + Business Media

    Clemens Decristoforo, Professor Hubertus Haas

  5. 68Ga-DOTA0-Tyr3-octreotide positron emission tomography in head and neck squamous cell carcinoma

    Article • European Journal of Pediatrics, May 2013, Springer Science + Business Media

    Clemens Decristoforo

  6. [68Ga]NS3-RGD and [68Ga] Oxo-DO3A-RGD for imaging αvβ3 integrin expression: synthesis, evaluation, and comparison

    Article • Nuclear Medicine and Biology, January 2013, Elsevier

    Clemens Decristoforo, Dr Christine Rangger

  7. Somatostatin receptor PET in neuroendocrine tumours: 68Ga-DOTA0,Tyr3-octreotide versus 68Ga-DOTA0-lanreotide

    Article • European Journal of Pediatrics, November 2012, Springer Science + Business Media

    Clemens Decristoforo

  8. Influence of PEGylation and RGD loading on the targeting properties of radiolabeled liposomal nanoparticles

    Article • International Journal of Nanomedicine, November 2012, Taylor & Francis

    Clemens Decristoforo, Dr Christine Rangger

  9. Microbial challenge tests on nonradioactive TiO2-based 68Ge/68Ga generator columns

    Article • Nuclear Medicine Communications, August 2012, Wolters Kluwer Health

    Clemens Decristoforo

  10. Gallium-68 – A New Opportunity For PET Available From a Long Shelflife Generator – Automation and Applications

    Article • Current Radiopharmaceuticals, June 2012, Bentham Science Publishers

    Clemens Decristoforo

  11. Preclinical evaluation of two 68Ga-siderophores as potential radiopharmaceuticals for Aspergillus fumigatus infection imaging

    Article • European Journal of Pediatrics, April 2012, Springer Science + Business Media

    Clemens Decristoforo, Professor Hubertus Haas

  12. Comparison of 68Ga-DOTATATE and 68Ga-DOTANOC PET/CT imaging in the same patient group with neuroendocrine tumours

    Article • European Journal of Pediatrics, April 2012, Springer Science + Business Media

    Clemens Decristoforo

  13. In vitro and in vivo evaluation of selected 68Ga-siderophores for infection imaging

    Article • Nuclear Medicine and Biology, April 2012, Elsevier

    Clemens Decristoforo, Professor Hubertus Haas

  14. Feasibility and availability of 68Ga-labelled peptides

    Article • European Journal of Pediatrics, February 2012, Springer Science + Business Media

    Clemens Decristoforo

  15. Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine: a clarification

    Article • European Journal of Pediatrics, January 2012, Springer Science + Business Media

    Clemens Decristoforo

  16. Targeting properties of peptide-modified radiolabeled liposomal nanoparticles

    Article • Nanomedicine Nanotechnology Biology and Medicine, January 2012, Elsevier

    Clemens Decristoforo, Dr Christine Rangger

  17. [ 99m Tc]Demotensin VI: Biodistribution and Initial Clinical Results in Tumor Patients of a Pilot/Phase I Study

    Article • Cancer Biotherapy & Radiopharmaceuticals, October 2011, Mary Ann Liebert Inc

    Clemens Decristoforo

  18. Radiolabelling of peptides for PET, SPECT and therapeutic applications using a fully automated disposable cassette system

    Article • Nuclear Medicine Communications, October 2011, Wolters Kluwer Health

    Clemens Decristoforo

  19. Preclinical Evaluation of Radiolabeled DOTA-Derivatized Cyclic Minigastrin Analogs for Targeting Cholecystokinin Receptor Expressing Malignancies

    Article • Molecular Imaging and Biology, July 2011, Springer Science + Business Media

    Clemens Decristoforo, Dr Christine Rangger

  20. Radiopharmacy: regulations and legislations in relation to human applications

    Article • Drug Discovery Today Technologies, June 2011, Elsevier

    Clemens Decristoforo

  21. Comparison of biological stability and metabolism of CCK2 receptor targeting peptides, a collaborative project under COST BM0607

    Article • European Journal of Pediatrics, April 2011, Springer Science + Business Media

    Clemens Decristoforo, Dr Christine Rangger

  22. [68Ga]NODAGA-RGD for imaging αvβ3 integrin expression

    Article • European Journal of Pediatrics, April 2011, Springer Science + Business Media

    Clemens Decristoforo, Dr Christine Rangger

  23. Influence of biological assay conditions on stability assessment of radiometal-labelled peptides exemplified using a 177Lu-DOTA-minigastrin derivative

    Article • Nuclear Medicine and Biology, February 2011, Elsevier

    Clemens Decristoforo

  24. Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine

    Article • European Journal of Pediatrics, January 2011, Springer Science + Business Media

    Clemens Decristoforo

  25. Radiotracer II: Peptide-Based Radiopharmaceuticals

    Article • January 2011, Springer Science + Business Media

    Clemens Decristoforo

  26. Novel 99mTc ‘4 + 1’ peptide conjugates: Tuning the biodistribution by variation of coligands

    Article • European Journal of Medicinal Chemistry, September 2010, Elsevier

    Clemens Decristoforo

  27. Comparison of 68Ga-siderophores for imaging Aspergillus fumigatus infections with PET

    Article • Nuclear Medicine and Biology, August 2010, Elsevier

    Clemens Decristoforo, Professor Hubertus Haas

  28. Guidance on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals

    Article • European Journal of Pediatrics, March 2010, Springer Science + Business Media

    Clemens Decristoforo

  29. Impurity in 68Ga-Peptide Preparation Using Processed Generator Eluate

    Article • Journal of Nuclear Medicine, February 2010, Society of Nuclear Medicine

    Clemens Decristoforo

  30. Full automation of 68Ga labelling of DOTA-peptides including cation exchange prepurification

    Article • Applied Radiation and Isotopes, February 2010, Elsevier

    Clemens Decristoforo

  31. Radiolabeling of lipid-based nanoparticles for diagnostics and therapeutic applications: a comparison using different radiometals

    Article • Journal of Liposome Research, October 2009, Taylor & Francis

    Clemens Decristoforo, Dr Christine Rangger

  32. Preclinical Evaluation of In-111 and Ga-68 Labelled Minigastrin Analogues for CCK-2 Receptor Imaging

    Article • Current Radiopharmaceuticals, October 2009, Bentham Science Publishers

    Clemens Decristoforo, Dr Christine Rangger

  33. Role of radiopharmaceuticals in the diagnosis and treatment of neuroendocrine tumours

    Article • European Journal of Cancer, September 2009, Elsevier

    Clemens Decristoforo

  34. Cyclic Minigastrin Analogues for Gastrin Receptor Scintigraphy with Technetium-99m: Preclinical Evaluation

    Article • Journal of Medicinal Chemistry, July 2009, American Chemical Society (ACS)

    Clemens Decristoforo

  35. Practical and general method for the direct synthesis of alkyl fluorides from alcohols under mild conditions: a reinvestigation

    Article • Monatshefte für Chemie - Chemical Monthly, September 2008, Springer Science + Business Media

    Clemens Decristoforo

  36. 68Ga- and 111In-labelled DOTA-RGD peptides for imaging of αvβ3 integrin expression

    Article • European Journal of Pediatrics, March 2008, Springer Science + Business Media

    Clemens Decristoforo

  37. A fully automated synthesis for the preparation of 68Ga-labelled peptides

    Article • Nuclear Medicine Communications, November 2007, Wolters Kluwer Health

    Clemens Decristoforo

  38. Therapy of differentiated thyroid cancer

    Article • October 2007, Taylor & Francis

    Clemens Decristoforo

  39. In Vitro and In Vivo Evaluation of a Novel 99mTc(CO)3-Pyrazolyl Conjugate of cyclo-(Arg-Gly-Asp-d-Tyr-Lys)

    Article • Bioconjugate Chemistry, January 2007, American Chemical Society (ACS)

    Clemens Decristoforo

  40. Evidence for Somatostatin receptor 2 in thyroid tissue

    Article • Regulatory Peptides, January 2007, Elsevier

    Clemens Decristoforo

  41. [99mTc]HYNIC-RGD for imaging integrin αvβ3 expression

    Article • Nuclear Medicine and Biology, November 2006, Elsevier

    Clemens Decristoforo

  42. Comparison of different methods for radiochemical purity testing of [99mTc-EDDA-HYNIC-D-Phe1,Tyr3]-Octreotide

    Article • Applied Radiation and Isotopes, February 2006, Elsevier

    Clemens Decristoforo

  43. Image fusion analysis of 99mTc-HYNIC-Tyr3-octreotide SPECT and diagnostic CT using an immobilisation device with external markers in patients with endocrine tumours

    Article • European Journal of Pediatrics, August 2005, Springer Science + Business Media

    Clemens Decristoforo

  44. Nuclear medicine in the detection and management of pancreatic islet-cell tumours

    Article • Best Practice & Research Clinical Endocrinology & Metabolism, June 2005, Elsevier

    Clemens Decristoforo

  45. Evaluation of [123I]IBZM pinhole SPECT for the detection of striatal dopamine D2 receptor availability in rats

    Article • NeuroImage, February 2005, Elsevier

    Clemens Decristoforo, Nadia Stefanova

  46. Radiopharmaceutical development of a freeze-dried kit formulation for the preparation of [99mTc-EDDA-HYNIC-D-Phe1, Tyr3]-octreotide, a somatostatin analog for tumor diagnosis

    Article • Journal of Pharmaceutical Sciences, October 2004, Elsevier

    Clemens Decristoforo

  47. 99m Tc-EDDA/HYNIC-TOC scintigraphy in oncological diagnostics: methodological considerations

    Article • European Journal of Pediatrics, February 2004, Springer Science + Business Media

    Clemens Decristoforo

  48. 99m Tc-N 4 -[Tyr 3 ]Octreotate Versus 99m Tc-EDDA/HYNIC-[Tyr 3 ]Octreotide: An Intrapatient Comparison of Two Novel Technetium-99m Labeled Tracers for Somatostatin Receptor Scintigraphy

    Article • Cancer Biotherapy & Radiopharmaceuticals, February 2004, Mary Ann Liebert Inc

    Clemens Decristoforo

  49. Analysis of accumulation of 99mTc-octreotide and 99mTc-EDDA/HYNIC-Tyr3-octreotide in the rat kidneys

    Article • Nuclear Medicine and Biology, February 2004, Elsevier

    Clemens Decristoforo

  50. 99mTc-EDDA/HYNIC-TOC and 18F-FDG in thyroid cancer patients with negative 131I whole-body scans

    Article • European Journal of Pediatrics, November 2003, Springer Science + Business Media

    Clemens Decristoforo

  51. Peptide Targeted Imaging of Cancer

    Article • Cancer Biotherapy & Radiopharmaceuticals, October 2003, Mary Ann Liebert Inc

    Clemens Decristoforo

  52. 99mTc-Demotate 1: first data in tumour patients?results of a pilot/phase I study

    Article • European Journal of Pediatrics, September 2003, Springer Science + Business Media

    Clemens Decristoforo

  53. Image fusion analysis of 99m Tc-HYNIC-octreotide scintigraphy and CT/MRI in patients with thyroid-associated orbitopathy: the importance of the lacrimal gland

    Article • European Journal of Pediatrics, August 2003, Springer Science + Business Media

    Clemens Decristoforo

  54. Preparation via coligand exchange and characterization of [99mTc‐EDDA‐HYNIC‐D‐Phe1,Tyr3]Octreotide (99mTc–EDDA/HYNIC–TOC)

    Article • Journal of Labelled Compounds and Radiopharmaceuticals, February 2003, Wiley

    Clemens Decristoforo

  55. Evaluation of Striatal Dopamine Transporter Function in Rats by in Vivo β-[123I]CIT Pinhole SPECT

    Article • NeuroImage, September 2002, Elsevier

    Clemens Decristoforo

  56. Somatostatin receptor scintigraphy using 99mTc-EDDA/HYNIC-TOC in Graves’ disease

    Article • European Journal of Pediatrics, August 2002, Springer Science + Business Media

    Clemens Decristoforo

  57. Erythroid 5‐aminolevulinate synthase, ferrochelatase and DMT1 expression in erythroid progenitors: differential pathways for erythropoietin and iron‐dependent regulation

    Article • British Journal of Haematology, July 2002, Wiley

    Clemens Decristoforo

  58. Authors’ reply to letter to the editor by G. Calmanovici

    Article • Nuclear Medicine and Biology, January 2002, Elsevier

    Clemens Decristoforo

  59. Methodological considerations influence the clinical value of parathyroid localisation diagnostics

    Article • European Journal of Pediatrics, July 2001, Springer Science + Business Media

    Clemens Decristoforo

  60. Surfactant protein B labelled with [99mTc(CO)3(H2O)3]+ retains biological activity in vitro

    Article • Nuclear Medicine and Biology, April 2001, Elsevier

    Clemens Decristoforo

  61. 53. Rhenium-188 labelling of HYNIC-octreotide analogues

    Article • Nuclear Medicine Communications, April 2001, Wolters Kluwer Health

    Clemens Decristoforo

  62. 99mTc-EDDA/HYNIC-TOC: a new 99mTc-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours: first clinical results and intra-patient comparison with 111In-labelled octreotide derivatives

    Article • European Journal of Pediatrics, June 2000, Springer Science + Business Media

    Clemens Decristoforo

  63. Human pharmacokinetics of a new 99mTc labelled somatostatin anlogue in comparison with 111In-labelled derivatives

    Article • Nuclear Medicine Communications, June 2000, Wolters Kluwer Health

    Clemens Decristoforo

  64. 11. First clinical assessment of a new Tc-99m-labelled somatostatin analogue

    Article • Nuclear Medicine Communications, April 2000, Wolters Kluwer Health

    Clemens Decristoforo

  65. 17. Pre-clinical development of a superior Tc-99m-labelled somatostatin analogue

    Article • Nuclear Medicine Communications, April 2000, Wolters Kluwer Health

    Clemens Decristoforo

  66. Radiochemical purity of routinely prepared 99Tcm radiopharmaceuticals: A retrospective study

    Article • Nuclear Medicine Communications, April 2000, Wolters Kluwer Health

    Clemens Decristoforo

  67. Technetium-99m somatostatin analogues: effect of labelling methods and peptide sequence

    Article • European Journal of Pediatrics, July 1999, Springer Science + Business Media

    Clemens Decristoforo

  68. Preparation, 99mTc-Labeling, and in Vitro Characterization of Hynic and N3S Modified RC-160 and [TYR3]octreotide

    Article • Bioconjugate Chemistry, July 1999, American Chemical Society (ACS)

    Clemens Decristoforo

  69. 99m-Technetium-labelled peptide-HYNIC conjugates: effects of lipophilicity and stability on biodistribution

    Article • Nuclear Medicine and Biology, May 1999, Elsevier

    Clemens Decristoforo

  70. Preparation, 99mTc-Labeling, and in Vitro Characterization of HYNIC and N3S Modified RC-160 and [Tyr3]Octreotide

    Article • Bioconjugate Chemistry, March 1999, American Chemical Society (ACS)

    Clemens Decristoforo

  71. Myocardial fatty acid metabolism during acute cardiac allograft rejection

    Article • Research in Experimental Medicine, September 1997, Springer Science + Business Media

    Clemens Decristoforo

  72. The use of electronic autoradiography in radiopharmacy

    Article • Nuclear Medicine and Biology, May 1997, Elsevier

    Clemens Decristoforo

  73. Brain perfusion scintigraphy with 99m Tc-HMPAO or 99m Tc-ECD and 123 I-β-CIT single-photon emission tomography in dementia of the Alzheimer-type and diffuse Lewy body disease

    Article • European Journal of Pediatrics, March 1997, Springer Science + Business Media

    Clemens Decristoforo

  74. Brain perfusion scintigraphy with99mTc-HMPAO or99mTc-ECD and123I-β-CIT single-photon emission tomography in dementia of the Alzheimer-type and diffuse Lewy body disease

    Article • European Journal of Pediatrics, March 1997, Springer Science + Business Media

    Clemens Decristoforo

  75. Evaluation of Immunological Mechanisms Mediating Thyroid-Associated Ophthalmopathy by Radionuclide Imaging Using the Somatostatin Analog 111 In-Octreotide

    Article • Thyroid, February 1997, Mary Ann Liebert Inc

    Clemens Decristoforo

  76. Training in Radiopharmaceutical Quality Control

    Article • January 1997, Springer Science + Business Media

    Clemens Decristoforo

  77. Bone scintigraphy versus human immunoglobulin scintigraphy in the clinical investigation of psoriatic arthropathy

    Article • European Journal of Pediatrics, November 1994, Springer Science + Business Media

    Clemens Decristoforo

  78. Technetium-99m human immunoglobulin scintigraphy in psoriatic arthropathy: first results

    Article • European Journal of Pediatrics, April 1994, Springer Science + Business Media

    Clemens Decristoforo

  79. Technetium-99m human immunoglobulin scintigraphy in psoriatic arthropathy: first results

    Article • European Journal of Pediatrics, April 1994, Springer Science + Business Media

    Clemens Decristoforo

  80. Failure of labelling of anti-granulocyte antibody

    Article • European Journal of Pediatrics, June 1993, Springer Science + Business Media

    Clemens Decristoforo

  81. A simple two-strip method to determine the radiochemical purity of technetium-99m mercaptoacetyltriglycine

    Article • European Journal of Pediatrics, April 1993, Springer Science + Business Media

    Clemens Decristoforo

  82. Quality Control Methods of 99mTc Pharmaceuticals

    Article • Springer Science + Business Media

    Clemens Decristoforo